Review
doi: 10.1038/nrd2355.
Utilizing RNA interference to enhance cancer drug discovery
Affiliations
- PMID: 17599085
- DOI: 10.1038/nrd2355
Item in Clipboard
Review
Utilizing RNA interference to enhance cancer drug discovery
Nat Rev Drug Discov.
2007 Jul.
Abstract
With the development of RNA interference (RNAi) libraries, systematic and cost-effective genome-wide loss-of-function screens can now be carried out with the aim of assessing the role of specific genes in neoplastic phenotypes, and the rapid identification of novel drug targets. Here, we discuss the existing applications of RNAi in cancer drug discovery and highlight areas in this process that may benefit from this technology in the future.
Similar articles
-
RNA interference screening for the discovery of oncology targets.Expert Opin Ther Targets. 2009 Sep;13(9):1027-35. doi: 10.1517/14728220903179338. Expert Opin Ther Targets. 2009. PMID: 19650760 Review.
-
Using iterative cluster merging with improved gap statistics to perform online phenotype discovery in the context of high-throughput RNAi screens.BMC Bioinformatics. 2008 Jun 5;9:264. doi: 10.1186/1471-2105-9-264. BMC Bioinformatics. 2008. PMID: 18534020 Free PMC article.
-
Expanding the repertoire of RNA interference screens for developing new anticancer drug targets.Expert Opin Ther Targets. 2007 Nov;11(11):1429-41. doi: 10.1517/14728222.11.11.1429. Expert Opin Ther Targets. 2007. PMID: 18028008 Review.
-
[RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer].Rev Invest Clin. 2010 Jan-Feb;62(1):63-80. Rev Invest Clin. 2010. PMID: 20415061 Review. Spanish.
-
RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin.Mol Pharmacol. 2005 Nov;68(5):1311-9. doi: 10.1124/mol.105.014191. Epub 2005 Aug 24. Mol Pharmacol. 2005. PMID: 16120770
Cited by
-
RNAi screening identifies KAT8 as a key molecule important for cancer cell survival.Int J Clin Exp Pathol. 2013 Apr 15;6(5):870-7. Print 2013. Int J Clin Exp Pathol. 2013. PMID: 23638218 Free PMC article.
-
Delivery strategies and potential targets for siRNA in major cancer types.Adv Drug Deliv Rev. 2016 Sep 1;104:2-15. doi: 10.1016/j.addr.2016.05.010. Epub 2016 May 31. Adv Drug Deliv Rev. 2016. PMID: 27259398 Free PMC article. Review.
-
A magnetic bead-integrated chip for the large scale manufacture of normalized esiRNAs.PLoS One. 2012;7(6):e39419. doi: 10.1371/journal.pone.0039419. Epub 2012 Jun 27. PLoS One. 2012. PMID: 22761791 Free PMC article.
-
Developing a Versatile Shotgun Cloning Strategy for Single-Vector-Based Multiplex Expression of Short Interfering RNAs (siRNAs) in Mammalian Cells.ACS Synth Biol. 2019 Sep 20;8(9):2092-2105. doi: 10.1021/acssynbio.9b00203. Epub 2019 Sep 10. ACS Synth Biol. 2019. PMID: 31465214 Free PMC article.
-
Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.Oncotarget. 2015 Sep 29;6(29):26841-60. doi: 10.18632/oncotarget.4754. Oncotarget. 2015. PMID: 26314964 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
